Grifols SA (GRFS)
7.31
+0.11
(+1.53%)
USD |
NASDAQ |
Sep 25, 15:30
Grifols Cash from Operations (TTM) : 1.264B for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.264B |
| March 31, 2026 | 1.172B |
| December 31, 2025 | 1.186B |
| September 30, 2025 | 1.257B |
| June 30, 2025 | 1.205B |
| March 31, 2025 | 1.305B |
| December 31, 2024 | 982.84M |
| September 30, 2024 | 580.09M |
| June 30, 2024 | 416.00M |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | 1.375B |
| December 31, 2020 | 1.277B |
| September 30, 2020 | 1.216B |
| June 30, 2020 | 1.071B |
| Date | Value |
|---|---|
| March 31, 2020 | 948.30M |
| December 31, 2019 | 641.78M |
| September 30, 2019 | 767.72M |
| June 30, 2019 | 738.25M |
| March 31, 2019 | 569.22M |
| December 31, 2018 | 873.59M |
| September 30, 2018 | 805.50M |
| June 30, 2018 | 843.01M |
| March 31, 2018 | 908.42M |
| December 31, 2017 | 949.43M |
| September 30, 2017 | 828.31M |
| June 30, 2017 | 835.94M |
| March 31, 2017 | 702.67M |
| December 31, 2016 | 612.03M |
| September 30, 2016 | 752.22M |
| June 30, 2016 | 728.67M |
| March 31, 2016 | 855.18M |
| December 31, 2015 | 829.23M |
| September 30, 2015 | 901.01M |
| June 30, 2015 | 1.036B |
| March 31, 2015 | 1.166B |
| December 31, 2014 | 1.298B |
| September 30, 2014 | 1.194B |
| June 30, 2014 | 967.04M |
| March 31, 2014 | 835.09M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| argenx SE | 1.160B |
| Evaxion AS | -- |
| Autolus Therapeutics Plc | -224.98M |
| Pharma Mar SA | 72.48M |
| Oryzon Genomics SA | -- |